𝔖 Bobbio Scriptorium
✦   LIBER   ✦

Matrix metalloproteinase-2 in blood does not indicate the progression of prostate cancer

✍ Scribed by Klaus Jung; Christian Laube; Michael Lein; Ingolf Türk; Ralf Lichtinghagen; Birgit Rudolph; Dietmar Schnorr; Stefan A. Loening

Publisher
John Wiley and Sons
Year
1998
Tongue
French
Weight
36 KB
Volume
78
Category
Article
ISSN
0020-7136

No coin nor oath required. For personal study only.

✦ Synopsis

studies on MMP-2 in PCa patients, we question the usefulness of pro-MMP-2 measurements in blood as a suitable predictor of the progression of prostate cancer.

Sincerely yours,

📜 SIMILAR VOLUMES

Matrix metalloproteinases 1 and 3, tissu
Matrix metalloproteinases 1 and 3, tissue inhibitor of metalloproteinase-1 and the complex of metalloproteinase-1/tissue inhibitor in plasma of patients with prostate cancer
✍ Klaus Jung; Lars Nowak; Michael Lein; Friedrich Priem; Dietmar Schnorr; Stefan A 📂 Article 📅 1997 🏛 John Wiley and Sons 🌐 French ⚖ 74 KB

We analyzed blood plasma concentrations of matrix metalloproteinase-1 and -3 (MMP-1; MMP-3), the tissue inhibitor of metalloproteinase-1 (TIMP-1) and the complex MMP-1/ TIMP-1, and looked for any correlation with prostate cancer stage. These components were measured by ELISA tests specific for these

Inhibition of caspase activity does not
Inhibition of caspase activity does not prevent the signaling phase of apoptosis in prostate cancer cells
✍ Denmeade, Samuel R.; Lin, Xiaohui S.; Tombal, Bertrand; Isaacs, John T. 📂 Article 📅 1999 🏛 John Wiley and Sons 🌐 English ⚖ 278 KB 👁 1 views

## BACKGROUND. Caspases are a family of cysteine proteases capable of characteristically cleaving after an aspartic acid residue. Various members of the caspase family (e.g., caspases 8 and 9) have been implicated as critical initiators in the signaling phase, while others (e.g., caspases 3, 6,and

Serum matrix metalloproteinase-2 and its
Serum matrix metalloproteinase-2 and its density in men with prostate cancer as a new predictor of disease extension
✍ Kazuo Gohji; Noboru Fujimoto; Isao Hara; Akio Fujii; Akinobu Gotoh; Hiroshi Okad 📂 Article 📅 1998 🏛 John Wiley and Sons 🌐 French ⚖ 97 KB 👁 1 views

We examined whether the serum matrix metalloproteinase-2 (MMP-2) level and MMP-2 density could be predictors of the development and extension of prostate cancer. Serum samples were collected before any clinical treatment from 98 patients with prostate cancer and from 76 patients with benign prostati